Louis J Lombardo

Years Active: 2020-2021
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Yong Zhang, Karen E Parrish, David R Tortolani, Michael A Poss, Audris Huang, Honghe Wan, Ashok V Purandare, Andrew F Donnell, James Kempson, Xiaoping Hou, Joseph Pawluczyk, Shiuhang Yip, Emily Luk, Nimmi Raghavan, Jesse Swanson, James Smalley, Anwar Murtaza, Zheng Yang, Karen Augustine-Rauch, Louis J Lombardo, Robert Borzilleri
Long-Acting Tumor-Activated Prodrug of a TGFβR Inhibitor. Journal of medicinal chemistry 64 (21) (2021)
Chunjian Liu, James Lin, Charles Langevine, Daniel Smith, Jianqing Li, John S Tokarski, Javed Khan, Max Ruzanov, Joann Strnad, Adriana Zupa-Fernandez, Lihong Cheng, Kathleen M Gillooly, David Shuster, Yifan Zhang, Anil Thankappan, Kim W McIntyre, Charu Chaudhry, Paul A Elzinga, Manoj Chiney, Anjaneya Chimalakonda, Louis J Lombardo, John E Macor, Percy H Carter, James R Burke, David S Weinstein
Discovery of BMS-986202: A Clinical Tyk2 Inhibitor that Binds to Tyk2 JH2. Journal of medicinal chemistry 64 (1) (2020)

Louis J Lombardo.css-eqlu8i{font-size:small;padding-left:4px;}